Foundation Medicine Announces 2017 Second Quarter Results and Recent Highlights

Go back to Foundation Medicine Announces 2017 Second Quarter Results and Recent Highlights

Foundation Medicine (FMI) Misses Q2 EPS by 13c

August 1, 2017 4:29 PM EDT

Foundation Medicine (NASDAQ: FMI) reported Q2 EPS of ($1.24), $0.13 worse than the analyst estimate of ($1.11). Revenue for the quarter came in at $35 million versus the consensus estimate of $34.94 million.

GUIDANCE:

Foundation Medicine sees FY2017 revenue of $135-145 million, versus the consensus of... More